International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis

Prim Care Respir J. 2006 Feb;15(1):58-70. doi: 10.1016/j.pcrj.2005.11.002. Epub 2005 Dec 27.


The association between the upper and lower airways has been recognised for almost 2000 years. Epidemiological data suggest that most asthma patients also suffer from allergic rhinitis, and that both diseases share similar trigger factors and pathophysiology. This IPCRG Guideline on the management of rhinitis in primary care is fully consistent with the ARIA guidelines. It highlights the treatment goals and the classification of the condition according to symptom frequency (intermittent or persistent) and severity (mild or moderate-severe). It covers the need for allergen avoidance, pharmacologic therapy including immunotherapy, alternative therapies, management of ocular symptoms, the management of co-existing allergic rhinitis and asthma, and the need for follow-up and ongoing care for patients with rhinitis.

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Allergic Agents / therapeutic use
  • Cholinergic Antagonists / therapeutic use
  • Chromones / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunotherapy
  • Leukotriene Antagonists / therapeutic use
  • Nasal Decongestants / therapeutic use
  • Pregnancy
  • Primary Health Care / standards*
  • Rhinitis, Allergic, Perennial / therapy*
  • Rhinitis, Allergic, Seasonal / therapy*


  • Anti-Allergic Agents
  • Cholinergic Antagonists
  • Chromones
  • Glucocorticoids
  • Leukotriene Antagonists
  • Nasal Decongestants